Bronchogen protocol

Course

Course (10–20 days)

20–40u

1–2 mg SubQ · Daily

SubQ. (Oral bioregulator dosing runs higher, 10–20 mg/day.)

Between courses

1–3 courses per year.

Phase	How often	Dose	Units	Notes
Course (10–20 days)	Daily	1–2 mg SubQ	20–40u	SubQ. (Oral bioregulator dosing runs higher, 10–20 mg/day.)
Between courses	–	–	–	1–3 courses per year.

Units column is labelled “Units (5 mg/mL)” on the page.

Cycle & timing

Cycle: 10–20 day course, 1–3×/year.

Timing: Any time.

Where: SubQ, abdomen. Rotate.

What to expect

Proposed respiratory-tissue support over a course; subtle, and evidence is preliminary.

How much to buy

For 20-day course @ 2 mg/day SubQ:

2

× 20mg vials

Men & women

Unisex peptide bioregulator, short courses, no sex-specific dosing; minimal human data. Avoid in pregnancy.

Dilution calculator

Set to the guide's typical mix for Bronchogen. Change anything to see where to draw.

Vial size

BAC water added

Dose you want

Draw to

40u

Volume

0.40 mL

Strength

5 mg/mL

Doses per vial

10

Assumes a U-100 insulin syringe (100 units = 1 mL). Double-check against the compound's page before you draw.

Recommended mixes

Vial	Water	Strength
20 mg	4 mL	5 mg/mL

20 mg: 1 unit = 0.05 mg. A 1–2 mg SubQ dose = 20–40 units.

Storage

PowderFreeze-dried: -4°F.
MixedReconstituted: 36–46°F, up to the course length.

Don't use if: Active malignancy (theoretical, tissue gene-expression modulation) · Pregnancy and lactation · Hypersensitivity to the peptide

Stop if you notice

Persistent injection-site reaction
Any unexpected respiratory or systemic symptom
Pregnancy

Side effects

Generally well tolerated, mild injection-site reaction. Human safety data limited.

Drug interactions

No well-characterized interactions. Commonly stacked with other bioregulators in a course.

Labs

None compound-specific; respiratory function tracking if that’s the goal

What these labs mean →

Warnings

Limited Western clinical data, most evidence is Russian research. Quality varies, request a COA. Subtle, course-based effects; not an acute therapy.

Patient education

A short-course, organ-targeted bioregulator; not continuous. Evidence is preliminary and largely Russian. Subtle effects; manage expectations. Request a COA; source quality matters.

These apply on top of the universal safety rules.

Pairs well with

Other Khavinson bioregulators

organ-specific stacks

Thymalin

immune

Thymalin

Epithalon

longevity

Epithalon

Avoid with

Active malignancy of the target tissue

bioregulator gene-expression effects, theoretical

Pregnancy

Can Bronchogen + Thymalin share a syringe?

Can share a syringe. Both are water-based. Combine them if you dose on the same schedule and site.

What it does

Bronchogen is a Khavinson tetrapeptide (Ala-Glu-Asp-Leu, AEDL) targeting bronchial/respiratory tissue. Like other peptide bioregulators, it is proposed to normalize tissue-specific gene expression and support repair in its target organ. Evidence is largely from Russian research; used in short pulsed courses.

Note

Respiratory-targeted bioregulator; evidence is largely Russian research, limited Western RCTs.

References

researchdosing peptidedosages PubMed thepeptidereport

From the guide, page 24.